11-15 11-16 11-17
2024-11-15（Friday）08:30-13:00
展开
L1, Pearl Hall
Youth Forum
08:30-10:05

第一节 [Youth Forum]

主持：
钱鹏旭 浙江大学
Moderator：
Pengxu Qian Zhejiang University
08:30-08:35

Opening

08:35-08:55

Proteome-Centric Multi-Omics Approach for Identifying Therapeutic Targets in Acute Myeloid Leukemia

王洪

中国医学科学院血液病医院

Hong Wang

Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences
08:55-09:15

Targeting Cell Death to Augment Cancer Immunotherapy

潘荣清

浙江大学

Rongqing Pan

Zhejiang University
09:15-09:35

The Role and Clinical Application of NK Cells in Pregnancy Complication

傅斌清

中国科学技术大学

Binqing Fu

University of Science and Technology of China
09:35-09:55

Clonal Hematopoiesis of Indeterminate Potential Links Periodontitis and Inflammatory Comorbidities

王辉

四川大学

Hui Wang

Sichuan University
09:55-10:05

Coffee Break

10:05-13:00

第二节 [Youth Forum]

主持：
程　辉 中国医学科学院血液病医院
Moderator：
Hui Cheng Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences
10:05-10:25

Single-cell Pan-leukemia Signatures of HSPC-like Blasts Predict Drug Response and Clinical Outcome

陈昌亚

中国医学科学院血液病医院

Changya Chen

Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences
10:25-10:45

Production of Human Enucleated RBCs ex vivo: Mechanisms and Applications

刘森泉

中国科学技术大学

Senquan Liu

University of Science and Technology of China
10:45-11:05

Design and Functional Study of Synthetic Cytokines

任俊明

浙江大学

Junming Ren

Zhejiang University
11:05-11:25

The Heterogeneity and Regulatory Mechanisms of T cells in Autoimmune Diseases

陈坤

同济大学

Kun Chen

Tongji University
11:25-11:45

Precise Regulation of Type I Interferon Signaling in T.gondii-mediated Cancer Immunotherapy

余潇

南方医科大学

Xiao Yu

Southern Medical University
12:00-13:00

Lunch

2024-11-15（Friday）08:30-13:00
展开
L3, Diamond Ballroom 4+5
Industrial Development Forum 产业发展论坛 （中文）
08:30-10:40

第一节 [Industrial Development Forum 产业发展论坛 （中文）]

主持：
魏国庆 浙江大学医学院附属第一医院
Moderator：
Guoqing Wei Zhejiang University
08:30-08:50

Opening and guest speech　开幕致辞

08:50-09:00

Exhibition Opening Ceremony　展商剪彩仪式

黄河 浙江大学 Akihiro Shimosaka ACTO,Japan Arnon Nagler Sheba Medical Center, Israel Didier Blaise Institut Paoli Calmettes, France

He Huang Zhejiang University Akihiro Shimosaka ACTO,Japan Arnon Nagler Sheba Medical Center, Israel Didier Blaise Institut Paoli Calmettes, France

09:00-09:20

基于监管探讨细胞制剂的质量控制

梁锦锋

浙江省药品化妆品审评中心

Jinfeng Liang

Zhejiang Provincial Center for Drug and Cosmetic Evaluation
09:20-09:40

细胞和基因治疗临床研究的规范管理和申请流程

赵青威

浙江大学

Qingwei Zhao

Zhejiang University
09:40-10:00

MRD阴性率作为MM研究主要终点探讨

MRD negative rate as primary endpoint in MM clinical trials

陈杰

南京驯鹿生物医药有限公司

Jie Chen

Nanjing lASO Medical Technology Co.. Ltd.
10:00-10:20

Next Generation CAR-T Technologies for Hematopoietic Malignancies.

何晓文

原启生物科技（上海）有限责任公司

Peter He

Oricell Therapeutics Holdings Limited
10:20-10:40

Coffee Break

10:40-13:00

第二节 [Industrial Development Forum 产业发展论坛 （中文）]

主持：
胡永仙 浙江大学
Moderator：
Yongxian Hu Zhejiang University
10:40-11:00

聚焦移植管线，重燃生命光彩

杨震

赛诺菲

Zhen Yang

Sanofi
11:00-11:20

中国细胞治疗药物的支付创新探索

Exploration of Payment Innovation for Cell Therapy Drugs in China

汪祥宁

复星凯瑞（上海）生物科技有限公司

Xiangning Wang

Shanghai Fosun Kairos Biotechnology Co., Ltd
11:20-11:40

Off-the-shelf Allogeneic CAR-T Cell Therapy for Autoimmune Diseases

郑彪

BRL Medicine Inc.

Biao Zheng

Shanghai Bangyao Biotechnology Co., Ltd
11:40-12:00

通用型 CAR-T 细胞的开发与展望

任江涛

南京北恒生物科技有限公司

Jiangtao Ren

Nanjing Beiheng Biotechnology Co., Ltd
12:00-13:00

Lunch

2024-11-15（Friday）13:30-17:30
展开
L1，Crystal Ballroom
Main venue A Plenary session I: Clinical & Translational Research
13:30-14:00

[Plenary session I: Clinical & Translational Research]

Opening ceremony [Main venue A Plenary session I: Clinical & Translational Research]

主持：
胡　豫 华中科技大学同济医学院附属协和医院
Moderator：
Yu Hu Concord Hospital affiliated with Tongji Medical College, Huazhong University of Science and Technology, China
致辞嘉宾：
黄　河 浙江大学 Mohamad Mohty Sorbonne University, France Akihiro Shimosaka ACTO,Japan
Guest speech：
He Huang Zhejiang University Mohamad Mohty Sorbonne University, France Akihiro Shimosaka ACTO,Japan
14:00-16:00

第一节 [Plenary session I: Clinical & Translational Research]

主持：
胡　豫 华中科技大学同济医学院附属协和医院 周道斌 中国医学科学院北京协和医院
Moderator：
Yu Hu Concord Hospital affiliated with Tongji Medical College, Huazhong University of Science and Technology, China Daobin Zhou Beijing Union Medical College Hospital, China
14:00-14:30

Novel Cellular Therapy for Hematological Malignant Diseases

黄河

浙江大学

He Huang

Zhejiang University
14:30-15:00

Using Marrow Infiltrating T cells to Treat Relapse After HSCT with PTCy

Leo Luznik

Baylor College of Medicine, USA

Leo Luznik

Baylor College of Medicine, USA
15:00-15:30

Points to Consider for Cellular Therapy

Akihiro Shimosaka

ACTO,Japan

Akihiro Shimosaka

ACTO,Japan
15:30-16:00

Coffee Break

16:00-17:30

第二节 [Plenary session I: Clinical & Translational Research]

主持：
刘启发 南方医科大学南方医院 徐开林 徐州医科大学附属医院
Moderator：
Qifa Liu Nanfang Hospital,Southern Medical University, China Kailin Xu Xuzhou Medical University Hospital, China
16:00-16:30

Type 2 Immunity May Hold Key to Long-term Cancer Remission

唐力

Swiss federal Institute of Technology in Lausanne，Switzerland

Li Tang

Swiss federal Institute of Technology in Lausanne，Switzerland
16:30-17:00

Integration of CAR-T into Total Therapy of Acute Lymphoblastic Leukemia

王建祥

中国医学科学院血液病医院

Jianxiang Wang

Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences
17:00-17:30

Allogenic CAR-T Cell Therapy for Autoimmune Diseases

徐沪济

海军军医大学

Huji Xu

Naval Medical University
2024-11-15（Friday）13:00-17:30
展开
L3，Diamond Ballroom 4+5
Main venue B Plenary session II: Advances in Immune Cell Therapy
13:00-13:20

[Plenary session II: Advances in Immune Cell Therapy]

Opening ceremony [Main venue B Plenary session II: Advances in Immune Cell Therapy]

主持：
黄　河 浙江大学 许琛琦 中国科学院分子细胞科学卓越创新中心
Moderator：
He Huang Zhejiang University Chenqi Xu Center for Excellence in Molecular Cell Science, CAS
13:25-15:40

第一节 [Plenary session II: Advances in Immune Cell Therapy]

主持：
王青青 浙江大学基础医学院 王东睿 浙江大学
Moderator：
Qingqing Wang Zhejiang University School of Medicine Dongrui Wang Zhejiang University
13:25-14:00

Myeloid-mediated Mechanisms of Resistance to Cancer Immunotherapy

Lawrence Fong

Fred Hutchinson Cancer Center, USA

Lawrence Fong

Fred Hutchinson Cancer Center, USA
14:00-14:35

Cell Injury and Tissue Homeostasis in Inflammatory Bowel Disease

陈家明

浙江大学

Jiaming Chen

Zhejiang University
14:35-15:00

Developing TCR-based Chimeric Antigen Receptor for Immunotherapy

林欣

清华大学

Xin Lin

Tsinghua University
15:00-15:25

Preclinical Assessment of the Efficacy andSafety of CAR-T Cell Therapy in Eosino-phil-associated Diseases

应颂敏

浙江大学

Songmin Ying

15:25-15:40

Coffee Break

15:40-17:30

第二节 [Plenary session II: Advances in Immune Cell Therapy]

主持：
陈　伟 浙江大学 蒋　晞 浙江大学
Moderator：
Jack Wei Chen School of Medicine, Zhejiang University Xi Jiang Zhejiang University
15:40-16:15

Harnessing Charge-mediated Immunoreceptor Signaling in T Cell Therapy

许琛琦

中国科学院分子细胞科学卓越创新中心

Chenqi Xu

Center for Excellence in Molecular Cell Science, CAS
16:15-16:40

CD7 CAR-T Bridged to allo-HSCT: Novel Strategies and Corresponding Mechanisms

胡永仙

浙江大学

Yongxian Hu

Zhejiang University
16:40-17:05

CAR-T Rational Design Driven by Artificial Intelligence

王皞鹏

上海科技大学

Haopeng Wang

ShanghaiTech University
17:05-17:30

Human T-cell Development and Aging

胡洪波

四川大学

Hongbo Hu

Sichuan University
2024-11-15（Friday）19:00-20:30
展开
L1，Crystal Ballroom
19:00-20:30

Welcome reception（L1，Crystal Ballroom／水晶宫）